Kanamycin – Injection Products
Recognized Interpretive Criteria
Additional FDA-identified interpretive criteria
|
Minimum Inhibitory |
Disk Diffusion |
||||
---|---|---|---|---|---|---|
Pathogen |
S |
I |
R |
S |
I |
R |
Enterobacterales |
M100 standard is recognized |
|||||
Staphylococcus aureus |
≤ 16 |
32 |
≥ 64 |
≥ 18 |
14-17 |
≤ 13 |
S = Susceptible; I = Intermediate; R = Resistant